Table 1.
HPV positive | ||||||
Detection method | Area or country | HPV types detected | N | % | Authors | Ref |
HB | Finland | – | 24/60 | 40 | Syrjänen 1982 | 7 |
HB | S Africa | – | 23/70 | 33 | Hille et al 1986 | 60 |
HB | S Africa | – | 13/20 | 65 | Hale et al 1989 | 61 |
HB | Venezuela | – | 2/2 | 100 | Matos et al 1990 | 62 |
HB | China | – | 25/51 | 49 | Chang et al 1990 | 63 |
IHC | S Africa | Ag | 7/70 | 10 | Hille et al 1986 | 60 |
IHC | Japan | Ag | 2/15 | 13 | Mori et al 1989 | 65 |
IHC | China | Ag | 7/31 | 23 | Mori et al 1989 | 65 |
IHC | Japan | Ag | 5/61 | 8 | Nakamura et al 1995 | 66 |
IHC, EM | Belgium | Ag, virions | 1/1 | 100 | van Cutsem et al 1991 | 29 |
IHC | Japan | Ag | 0/4 | 0 | Kuwano et al 2001 | 67 |
FISH | Australia | 11, 13, 16, 18 | 5/10 | 50 | Kulski et al 1986 | 68 |
FISH | China | 11, 16, 18 | 3/80 | 66 | Chang et al 1990 | 69 |
HISTOFISH | Australia | 6, 11, 16, 18 | 9/39 | 23 | Kulski et al 1990 | 70 |
Slot blot | Hong Kong | 6, 11, 16, 18 | 0/37 | 0 | Loke et al 1990 | 71 |
Dot blot | France | 6/11, 16/18 | 5/12 | 42 | Benamouzig et al 1992 | 72 |
SB | China | 16 | 12/24 | 50 | Li et al 1991 | 73 |
SB | China | 11, 16, 18, 30 | 8/20 | 40 | Chang et al 1992 | 74 |
SB, PCR | China | 16, 18 | 0/35 | 0 | Lu et al 1995 | 75 |
SB, PCR | China | 16, 18 | 37/103 | 36 | He et al 1996 | 76 |
ISH | China | 6, 11, 16, 18 | 22/51 | 43 | Chang et al 1990 | 63 |
ISH | France | 6, 11, 16, 18, 31, 33 | 1/12 | 8 | Benamouzig et al 1992 | 72 |
ISH | UK | 6, 11, 16, 18, 31, 33 | 0/4 | 0 | Ashworth et al 1993 | 77 |
ISH | China | 6, 11, 16, 18, 30… | 85/363 | 23 | Chang et al 1993 | 78 |
ISH | S Africa | 6, 7, 16, 18, 30 | 3/10 | 30 | van Rensburg et al 1993 | 79 |
ISH | Japan | 6, 11, 16, 18, 31, 33 | 24/71 | 34 | Furihata et al 1993 | 80 |
ISH | Japan | 16, 18 | 13/42 | 31 | Ono et al 1994 | 81 |
ISH | S Africa | 6, 11, 18, 31, 33 | 25/48 | 52 | Cooper 1995 | 82 |
ISH | Korea | Wide spectrum | 11/25 | 44 | Woo et al 1996 | 46 |
ISH | China | Wide spectrum | 3/36 | 8 | Chang et al 1997 | 83 |
ISH | Japan | 6, 11, 16, 18 | 37/123 | 30 | Takahashi et al 1998 | 84 |
ISH | China | 6, 11, 16, 18, 30, 53 | 117/700 | 17 | Chang et al 2000 | 11 |
PCR | USA | 16/18 | 0/13 | 0 | Kiyabu et al 1989 | 85 |
PCR | S Africa | Various | 6/14 | 43 | Williamson et al 1991 | 86 |
PCR | Korea | 16, 18 | 16/24 | 67 | Kim et al 1991 | 87 |
PCR | Japan | 16, 18, CP | 3/45 | 7 | Toh et al 1992 | 88 |
PCR | China | 6, 11, 16, 18 | 25/51 | 49 | Chang et al 1992 | 74 |
PCR | Slovenia | CP | 2/20 | 10 | Poljak and Cerar 1993 | 89 |
PCR | China | GP | 24/40 | 60 | Chen et al 1994 | 90 |
PCR | Sweden | GP | 0/10 | 0 | Lewensohn-Fuchs et al 1994 | 91 |
PCR | Different | CP, 16, 18 | 10/72 | 14 | Togawa et al 1994 | 92 |
PCR | S Africa | E6, GP | 6/9 | 67 | Cooper et al 1995 | 93 |
PCR | France | 6, 11, 16, 18, 31, 33 | 0/75 | 0 | Benamouzig et al 1995 | 94 |
PCR | Japan | CP | 0/31 | 0 | Akutsu et al 1995 | 95 |
PCR | Japan | CP | 3/45 | 7 | Sugimachi et al 1995 | 96 |
PCR | Japan | CP | 15/72 | 21 | Shibagaki et al 1995 | 97 |
PCR | Holland | CP | 0/61 | 0 | Smits et al 1995 | 98 |
PCR | Portugal | 16, 18 | 9/16 | 56 | Fidalgo et al 1995 | 99 |
PCR | China | 6, 16, 18 | 3/70 | 4 | Suzuk et al 1996 | 100 |
PCR | USA | 6, 16, 18 | 1/23 | 4 | Suzuk et al 1996 | 100 |
PCR | USA | 73 | 1/1 | 100 | West et al 1996 | 101 |
PCR | France | – | 0/75 | 0 | Benamouzig et al 1996 | 23 |
PCR | China | 16, 18 | 32/152 | 21 | He et al 1997 | 102 |
PCR | Holland | CP | 0/63 | 0 | Kok et al 1997 | 103 |
PCR | Hong Kong | CP, SSCP | 6/75 | 9 | Lam et al 1997 | 104 |
PCR | Alaska | CP | 10/22 | 45 | Miller et al 1997 | 105 |
PCR | Japan | 18 | 3/41 | 7 | Mizobuchi et al 1997 | 106 |
PCR | UK | – | 0/22 | 0 | Morgan et al 1997 | 107 |
PCR | USA | – | 0/11 | 0 | Paz et al 1997 | 108 |
PCR | Italy | – | 0/18 | 0 | Rugge et al 1997 | 109 |
PCR | USA | CP, RFLP, 16 | 1/51 | 2 | Turner et al 1997 | 110 |
PCR | Japan | CP, 16, 18 | 0/103 | 0 | Saegusa et al 1997 | 111 |
PCR | Slovenia | CP, 6, 16, 18 | 0/121 | 0 | Poljak et al 1998 | 15 |
PCR | Japan | CP, 16, 18 | 17/27 | 63 | Khurshid et al 1998 | 112 |
PCR | Japan | CP, 16, 18 | 3/24 | 12 | Takahashi et al 1998 | 84 |
PCR | China, S Africa | CP | 19/63 | 30 | Lavergne et al 1999 | 49 |
PCR | China | CP | 20/117 | 17 | de Villiers et al 1999 | 113 |
PCR | Italy | CP, 16, 18 | 0/45 | 0 | Talamini et al 2000 | 50 |
PCR | Japan | CP | 12/75 | 16 | Kawaguchi et al 2000 | 114 |
PCR | Belgium | CP | 1/21 | 2 | Lambot et al 2000 | 115 |
PCR | China | CP | 2/32 | 6 | Peixoto-Guimaraes 2001 | 116 |
PCR | China | CP | 17/101 | 17 | Chang et al 2000 | 12 |
PCR | India | CP | 25/40 | 63 | Sobti et al 2001 | 117 |
PCR | Italy | CP, RFLP | 8/17 | 47 | Astori et al 2001 | 118 |
Ag, HPV antigens; CP, consensus primers; EM, electron microscopy; FISH, filter in situ hybridisation; GP, general primers; HB, histological biopsy; IHC, immunohistochemistry; ISH, in situ hybridization; PCR, polymerase chain reaction; RFLP, restriction fragment length polymorphism; SB, Southern blot hybridisation.